Ad is loading...
MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gain Therapeutics (GANX) Ownership - Who owns Gain Therapeutics?
Profile
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
47.11M
P/E Ratio
N/A
Total Cash
16.94M
Projected Growth
N/A
Total Debt
807.57K
Revenue
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GANX
Capitalization
47.1M
P/E Ratio
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash
16.9M
Total Cash/Share
0.66
Total Debt
808K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
11.8M
P/B Ratio
4.00
Cash Flow
N/A
Earnings
-1.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.52K
Current Ratio
2.84
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-115.33
Shares Held By Institutions
3.86M
Shares Outstanding - Current
25.5M
Total Liabilities
7.41M
Total Volume MTD
N/A
Value
-1
Gain YTD
-43.492
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com